Skip to main content
Erschienen in: Clinical Research in Cardiology 12/2016

05.07.2016 | Original Paper

BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure

verfasst von: Òscar Miró, Christian Müller, Francisco Javier Martín-Sánchez, Héctor Bueno, Alexander Mebazaa, Pablo Herrero, Javier Jacob, Víctor Gil, Rosa Escoda, Pere Llorens, ICA-SEMES Research Group

Erschienen in: Clinical Research in Cardiology | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Objective

To evaluate the effects of discontinuing chronic beta-blocker (BB) treatment on short-term outcome in patients with chronic heart failure (CHF) during acute decompensation.

Methods

We selected all the patients previously diagnosed with CHF and currently on BB and attended for acute heart failure (AHF) in one of the 35 Spanish emergency departments participating in the EAHFE registry. Patients were classified according to BB maintenance or withdrawal (BBM or BBW, respectively) during the episode. In-hospital mortality was the primary endpoint; and 30-day mortality, 30-day combined endpoint, and prolonged hospitalization were secondary. We used logistic regression for adjustment of results according to the differences between the BBM and BBW groups, and stratified analysis by age, sex, left ventricular ejection fraction, chronic obstructive pulmonary disease, heart rate (HR), and BB type (carvedilol/bisoprolol) was performed.

Results

Among 2058 patients receiving chronic BB treatment, 1990 were analyzed: BBM 530 (27 %), BBW 1460 (73 %). Compared to BBM, BBW had a higher in-hospital mortality (5.5 vs 3.0 %; p < 0.05), 30-day mortality (8.7 vs 4.5 %; p < 0.01), and 30-day combined endpoint (29.8 vs 23.4 %; p < 0.05). Multivariate adjustment confirmed an independent direct association between BBW and in-hospital mortality (OR 1.89; 95 % CI 1.09–3.26) and 30-day mortality (OR 2.01; 95 % CI 1.28–3.15). Stratified analysis indicated no interaction by all the subgroups analyzed, except for HR (p = 0.01 for interaction), which showed a greater negative impact of BBW in patients with HR >80 bpm (OR 2.74; 95 % CI 1.13–6.63).

Conclusions

In the absence of clear contraindications, BB treatment should be maintained during AHF episodes in patients already receiving BB at home.
Literatur
1.
Zurück zum Zitat Ohlmeier C, Mikolajczyk R, Frick J, Prütz F, Haverkamp W, Garbe E (2015) Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol 104:688–696CrossRefPubMed Ohlmeier C, Mikolajczyk R, Frick J, Prütz F, Haverkamp W, Garbe E (2015) Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol 104:688–696CrossRefPubMed
2.
Zurück zum Zitat Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216CrossRefPubMed Adams KF Jr, Fonarow GC, Emerman CL et al (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209–216CrossRefPubMed
3.
Zurück zum Zitat Cleland JG, Swedberg K, Follath F et al (2003) The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442–463CrossRefPubMed Cleland JG, Swedberg K, Follath F et al (2003) The EuroHeart Failure survey programme—a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24:442–463CrossRefPubMed
4.
Zurück zum Zitat Weintraub NL, Collins SP, Pang PS, American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation et al (2010) Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 122:1975–1996CrossRefPubMed Weintraub NL, Collins SP, Pang PS, American Heart Association Council on Clinical Cardiology and Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation et al (2010) Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association. Circulation 122:1975–1996CrossRefPubMed
5.
Zurück zum Zitat Llorens P, Manito Lorite N, Manzano Espinosa L et al (2015) Consensus on improving the care integrated of patients with acute heart failure. Emergencias 27:245–266 Llorens P, Manito Lorite N, Manzano Espinosa L et al (2015) Consensus on improving the care integrated of patients with acute heart failure. Emergencias 27:245–266
6.
Zurück zum Zitat Llorens P, Escoda R, Miró O et al (2015) Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (Epidemiology of Acute Heart Failure in Emergency Departments). Emergencias 27:11–22 Llorens P, Escoda R, Miró O et al (2015) Characteristics and clinical course of patients with acute heart failure and the therapeutic measures applied in Spanish emergency departments: based on the EAHFE registry (Epidemiology of Acute Heart Failure in Emergency Departments). Emergencias 27:11–22
7.
Zurück zum Zitat (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001–2007 (1999) Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353:2001–2007
8.
Zurück zum Zitat (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9–13 (1999) The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 353:9–13
9.
Zurück zum Zitat Packer M, Coats AJ, Fowler MB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658CrossRefPubMed Packer M, Coats AJ, Fowler MB et al (2001) Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344:1651–1658CrossRefPubMed
10.
Zurück zum Zitat McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847CrossRefPubMed
11.
Zurück zum Zitat Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–e239CrossRefPubMed Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Drazner MH et al (2013) 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147–e239CrossRefPubMed
12.
Zurück zum Zitat Bueno H (2015) Acute heart failure in Spain: certainties and uncertainties. Emergencias 27:7–9 Bueno H (2015) Acute heart failure in Spain: certainties and uncertainties. Emergencias 27:7–9
13.
Zurück zum Zitat Jondeau G, Milleron O (2015) Beta-blockers in acute heart failure. JACC Heart Fail 3:654–656CrossRefPubMed Jondeau G, Milleron O (2015) Beta-blockers in acute heart failure. JACC Heart Fail 3:654–656CrossRefPubMed
14.
Zurück zum Zitat Mueller C, Christ M, Cowie M et al (2015) European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: a call for interdisciplinary care. Eur Heart J Acute Cardiovasc Care. doi:10.1177/2048872615593279 Mueller C, Christ M, Cowie M et al (2015) European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: a call for interdisciplinary care. Eur Heart J Acute Cardiovasc Care. doi:10.​1177/​2048872615593279​
15.
Zurück zum Zitat Bueno H (2015) Cardiovascular research continuity: a call to increase collaboration between cardiology and emergency care research. Emergencias 27:396–398 Bueno H (2015) Cardiovascular research continuity: a call to increase collaboration between cardiology and emergency care research. Emergencias 27:396–398
16.
Zurück zum Zitat Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S (2015) Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis. JACC Heart Fail 3:647–653CrossRefPubMedPubMedCentral Prins KW, Neill JM, Tyler JO, Eckman PM, Duval S (2015) Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis. JACC Heart Fail 3:647–653CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Orso F, Baldasseroni S, Fabbri G, Gonzini L, Lucci D, D’Ambrosi C et al (2009) Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian survey on acute heart failure. Eur J Heart Fail 11:77–84CrossRefPubMed Orso F, Baldasseroni S, Fabbri G, Gonzini L, Lucci D, D’Ambrosi C et al (2009) Role of beta-blockers in patients admitted for worsening heart failure in a real world setting: data from the Italian survey on acute heart failure. Eur J Heart Fail 11:77–84CrossRefPubMed
18.
Zurück zum Zitat Bohm M, Link A, Cai D, Nieminen MS, Filippatos GS, Salem R et al (2011) Beneficial association of beta-blocker therapy on recovery from severe acute heart failure treatment: data from the survival of patients with acute heart failure in need of intravenous inotropic support trial. Crit Care Med 39:940–944CrossRefPubMed Bohm M, Link A, Cai D, Nieminen MS, Filippatos GS, Salem R et al (2011) Beneficial association of beta-blocker therapy on recovery from severe acute heart failure treatment: data from the survival of patients with acute heart failure in need of intravenous inotropic support trial. Crit Care Med 39:940–944CrossRefPubMed
19.
Zurück zum Zitat Butler J, Young JB, Abraham WT, Bourge RC, Adams KF Jr, Clare R et al (2006) Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 47:2462–2469CrossRefPubMed Butler J, Young JB, Abraham WT, Bourge RC, Adams KF Jr, Clare R et al (2006) Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 47:2462–2469CrossRefPubMed
20.
Zurück zum Zitat Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH et al (2008) Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 52:190–199CrossRefPubMed Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH et al (2008) Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program. J Am Coll Cardiol 52:190–199CrossRefPubMed
21.
Zurück zum Zitat Gattis WA, O’Connor CM, Leimberger JD, Felker GM, Adams KF, Gheorghiade M (2003) Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. Am J Cardiol 91:169–174CrossRefPubMed Gattis WA, O’Connor CM, Leimberger JD, Felker GM, Adams KF, Gheorghiade M (2003) Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. Am J Cardiol 91:169–174CrossRefPubMed
22.
Zurück zum Zitat Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M et al (2009) B-CONVINCED: beta-blocker CONtinuation vs. INterruption in patients with congestive heart failure hospitalized for a decompensation episode. Eur Heart J 30:2186–2192CrossRefPubMed Jondeau G, Neuder Y, Eicher JC, Jourdain P, Fauveau E, Galinier M et al (2009) B-CONVINCED: beta-blocker CONtinuation vs. INterruption in patients with congestive heart failure hospitalized for a decompensation episode. Eur Heart J 30:2186–2192CrossRefPubMed
23.
Zurück zum Zitat Miró O, Escoda R, Martín-Sánchez FJ, Herrero P, Jacob J, Alquézar A et al (2015) Acute heart failure patient perceived quality with respect to the health care provided at the emergency department: CALPERICA Study. Emergencias 7:161–168 Miró O, Escoda R, Martín-Sánchez FJ, Herrero P, Jacob J, Alquézar A et al (2015) Acute heart failure patient perceived quality with respect to the health care provided at the emergency department: CALPERICA Study. Emergencias 7:161–168
24.
Zurück zum Zitat Miró O, Gil V, Müller C, Mebazaa A, Bueno H, Martín-Sánchez FJ et al (2015) How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry. Clin Res Cardiol 104:850–860CrossRefPubMed Miró O, Gil V, Müller C, Mebazaa A, Bueno H, Martín-Sánchez FJ et al (2015) How does a clinical trial fit into the real world? The RELAX-AHF study population into the EAHFE registry. Clin Res Cardiol 104:850–860CrossRefPubMed
25.
Zurück zum Zitat Ho KKL, Anderson KM, Kannel WB, Grosssman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115CrossRefPubMed Ho KKL, Anderson KM, Kannel WB, Grosssman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115CrossRefPubMed
26.
Zurück zum Zitat Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH et al (2008) Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 52:347–356CrossRefPubMed Abraham WT, Fonarow GC, Albert NM, Stough WG, Gheorghiade M, Greenberg BH et al (2008) Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). J Am Coll Cardiol 52:347–356CrossRefPubMed
27.
Zurück zum Zitat Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I et al (2011) The Romanian Acute Heart Failure Syndromes (ROAHFS) registry. Am Heart J 162:142–153CrossRefPubMed Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I et al (2011) The Romanian Acute Heart Failure Syndromes (ROAHFS) registry. Am Heart J 162:142–153CrossRefPubMed
28.
Zurück zum Zitat Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, EuroHeart Survey Investigators, Heart Failure Association, European Society of Cardiology et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725–2736CrossRefPubMed Nieminen MS, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, EuroHeart Survey Investigators, Heart Failure Association, European Society of Cardiology et al (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725–2736CrossRefPubMed
29.
Zurück zum Zitat Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T (2015) General practitioners’ adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clin Res Cardiol (Epub ahead of print) (PubMed PMID: 26552905) Hirt MN, Muttardi A, Helms TM, van den Bussche H, Eschenhagen T (2015) General practitioners’ adherence to chronic heart failure guidelines regarding medication: the GP-HF study. Clin Res Cardiol (Epub ahead of print) (PubMed PMID: 26552905)
30.
Zurück zum Zitat Salpeter S, Ormiston T, Salpeter E (2005) Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev:CD003566 Salpeter S, Ormiston T, Salpeter E (2005) Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev:CD003566
31.
Zurück zum Zitat Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK et al (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103:149–159CrossRefPubMed Lonn EM, Rambihar S, Gao P, Custodis FF, Sliwa K, Teo KK et al (2014) Heart rate is associated with increased risk of major cardiovascular events, cardiovascular and all-cause death in patients with stable chronic cardiovascular disease: an analysis of ONTARGET/TRANSCEND. Clin Res Cardiol 103:149–159CrossRefPubMed
32.
Zurück zum Zitat Li SJ, Sartipy U, Lund LH, Dahlström U, Adiels M, Petzold M et al (2015) Prognostic significance of resting heart rate and use of β-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry. Circ Heart Fail 8:871–879CrossRefPubMed Li SJ, Sartipy U, Lund LH, Dahlström U, Adiels M, Petzold M et al (2015) Prognostic significance of resting heart rate and use of β-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry. Circ Heart Fail 8:871–879CrossRefPubMed
33.
Zurück zum Zitat Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG et al (2014) Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384:2235–2243CrossRefPubMed Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG et al (2014) Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. Lancet 384:2235–2243CrossRefPubMed
34.
Zurück zum Zitat de Groote P, Isnard R, Assyag P et al (2007) Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 9:1205–1211CrossRefPubMed de Groote P, Isnard R, Assyag P et al (2007) Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey. Eur J Heart Fail 9:1205–1211CrossRefPubMed
35.
Zurück zum Zitat Antonini P, Magrini L, Murphy M, Di Somma S (2015) Multidisciplinary participation for research in the emergency setting. Emergencias 27:399–402 Antonini P, Magrini L, Murphy M, Di Somma S (2015) Multidisciplinary participation for research in the emergency setting. Emergencias 27:399–402
36.
Zurück zum Zitat Cohen Solal A, Leurs I, Assyag P et al (2012) Optimization of heart failure medical treatment after hospital discharge according to left ventricular ejection fraction: the FUTURE survey. Arch Cardiovasc Dis 05:355–365CrossRef Cohen Solal A, Leurs I, Assyag P et al (2012) Optimization of heart failure medical treatment after hospital discharge according to left ventricular ejection fraction: the FUTURE survey. Arch Cardiovasc Dis 05:355–365CrossRef
Metadaten
Titel
BETAWIN-AHF study: effect of beta-blocker withdrawal during acute decompensation in patients with chronic heart failure
verfasst von
Òscar Miró
Christian Müller
Francisco Javier Martín-Sánchez
Héctor Bueno
Alexander Mebazaa
Pablo Herrero
Javier Jacob
Víctor Gil
Rosa Escoda
Pere Llorens
ICA-SEMES Research Group
Publikationsdatum
05.07.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 12/2016
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1014-9

Weitere Artikel der Ausgabe 12/2016

Clinical Research in Cardiology 12/2016 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.